Massachusetts Financial Services Co. MA acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 96,199 shares of the company's stock, valued at approximately $2,020,000. Massachusetts Financial Services Co. MA owned 0.24% of Phibro Animal Health as of its most recent SEC filing.
Several other large investors have also bought and sold shares of the company. Quantbot Technologies LP increased its holdings in shares of Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after buying an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth $113,000. New York State Teachers Retirement System lifted its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after purchasing an additional 775 shares during the last quarter. Amundi boosted its position in shares of Phibro Animal Health by 185.5% in the 4th quarter. Amundi now owns 9,855 shares of the company's stock valued at $212,000 after purchasing an additional 6,403 shares during the period. Finally, Zacks Investment Management purchased a new position in Phibro Animal Health in the 3rd quarter worth about $274,000. Institutional investors own 99.34% of the company's stock.
Phibro Animal Health Stock Up 0.1 %
Phibro Animal Health stock traded up $0.02 during trading hours on Monday, hitting $17.52. The company had a trading volume of 15,365 shares, compared to its average volume of 188,937. The firm's fifty day moving average is $22.20 and its 200-day moving average is $22.46. The firm has a market capitalization of $709.53 million, a P/E ratio of 36.49, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63. Phibro Animal Health Co. has a fifty-two week low of $12.30 and a fifty-two week high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.
Phibro Animal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.74%. Phibro Animal Health's dividend payout ratio (DPR) is 100.00%.
Analyst Ratings Changes
Several research analysts have commented on PAHC shares. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research note on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, Phibro Animal Health presently has a consensus rating of "Hold" and an average price target of $21.00.
Get Our Latest Analysis on Phibro Animal Health
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
